Current Edition

Challenges of Drug Development in Progressive Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterised with focal confluent lesions of primary demyelination followed by diffuse axonal damage and neurodegeneration in the entire CNS. Tomislav Babic at Worldwide Clinical Trials discusses how disease onset and clinical course are highly variable and mostly unpredictable.

[gview file=””]